Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11)
Edan G, Freedman M, Montalban X, Miller D, Hartung H, Hemmer B, Fox E, Barkhof F, Schippling S, Schulze A, et al., Neurology 2015 Apr; 84(14) Supplement P7.012
Accessed on 19 May 2015 from http://www.neurology.org/content/84/14_Supplement/P7.012.short?rss=1.
